YouAreCreators Podcast Ep6: Three Simple Steps To Success! (Law Of Attraction)

http://youtu.be/sSYfDl_kjrY

Purchase Trevor"s book here: http://www.amazon.com/Trevor-Blake/e/B006LPCEPW
Visit Trevor"s website here: http://trevorgblake.com/

Author of Three Simple Steps, Trevor Blake, knows a thing or two about breaking the mold. Born into poverty, he developed a knack for entrepreneurialism when riding the school bus at the age of twelve. Noting how much his classmates enjoyed sweets, he bought a bulk supply of treats one day and sold them to his fellow travelers. With money in his hand at the end of the day, he learned a thing or two about taking initiative.

Blake has translated his entrepreneurial gifts into a successful career in the pharmaceutical industry. With an MBA from Durham University (UK), and a degree in radiation physics and nuclear medicine, Blake was also a graduate of Britannia Royal Navy College, where he became the first person in his province ever to be awarded a reserved place. Blake has over 20 years of experience as a commercial development leader with successful biotechnology and pharmaceutical companies. This led to his definitive success in 2002 as founder and CEO of America"s most successful "non-employer business," QOL Medical LLC, a company focused on solutions for rare diseases that he started with just a few thousand dollars. By 2008, QOL was earning $20 million a year in revenues with gross profits of 83%, while developing five medicines used to treat rare diseases, mostly in children. Despite having no facility or employees, QOL provided medicines all over the world, and also set up a compassionate use program that allowed over 25% of patients to receive free medication and allowed no patient to pay more than a $30 co-pay. QOL sold in 2010 for over $100 million. Blake also founded ANU Oncology in 2006, a unique virtually-structured company focused on developing cancer treatments, which he sold in 2011 to Taiwan-based New Pacific for an undisclosed fee. Blake retains a 33% stake in the ensuing joint-venture, Neovia Oncology Ltd.